Ukko is developing a pipeline of revolutionary drugs to cure life-threatening allergies, starting with food allergies. Our lead product treats peanut allergy and will be the first in a line of first-in-class and best-in-class allergy treatments that are safer, more efficacious, work faster and provide better experience for patients compared to the alternatives. Our computational protein design platform can be readily and robustly applied to any allergenic protein.
“In working with the PeakBridge team, we have found true partners for our journey. Driven by their passion for impacting the worlds of health and food, the PeakBridge team leverages their understanding of the food space and their extensive connections to help us achieve our goals faster and better.”